Cite
Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line
MLA
Jin-Jian Lu, et al. “Characterization of Osimertinib (AZD9291)-Resistant Non-Small Cell Lung Cancer NCI-H1975/OSIR Cell Line.” Oncotarget, vol. 7, Nov. 2016, pp. 81598–610. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eed3862017a6e2cbbfb148d70e8ec647&authtype=sso&custid=ns315887.
APA
Jin-Jian Lu, Xiao-Ming Jiang, Chi Man Vivienne Fong, Xia Guo, Xiuping Chen, & Zheng-Hai Tang. (2016). Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line. Oncotarget, 7, 81598–81610.
Chicago
Jin-Jian Lu, Xiao-Ming Jiang, Chi Man Vivienne Fong, Xia Guo, Xiuping Chen, and Zheng-Hai Tang. 2016. “Characterization of Osimertinib (AZD9291)-Resistant Non-Small Cell Lung Cancer NCI-H1975/OSIR Cell Line.” Oncotarget 7 (November): 81598–610. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eed3862017a6e2cbbfb148d70e8ec647&authtype=sso&custid=ns315887.